Avis Budget Group, Inc. (CAR)

Caxton Associates LLP purchased a new position in Avis Budget Group, Inc. (NASDAQ: CAR) during the undefined quarter, according to its most recent 13F filing with the SEC. The firm purchased 27,377 sh...

Valvoline CEO Lori Flees discusses the used car boom, decreased interest in electric vehicles and more on ‘The Claman Countdown.' #fox #media #breakingnews #us #usa #new #news #breaking #theclamancoun...

Toronto-based Maple Rock Capital Partners sold 415,584 shares of Avis Budget Group in the third quarter. The move marked a full exit for Maple Rock, effectively eliminating a position previously value...

PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #Breyanzi--BMS's Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory Marginal Zone Lymphoma (MZL...

Franklin Resources Inc. acquired a new stake in Avis Budget Group, Inc. (NASDAQ: CAR) during the second quarter, according to its most recent disclosure with the SEC. The institutional investor acquir...

Avis Budget (CAR) reported earnings 30 days ago. What's next for the stock?...

PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #Breyanzi--BMS Receives Approval from the European Commission to Expand Use of CAR T Cell Therapy Breyanzi for Relapsed or Refractory Mantle Cell Lymphoma....

NOVEL THREE-PART ONLINE AUCTION TO INCLUDE EUROPE AND UK-BASED COLLECTOR CARS ALONGSIDE MOTORSPORT MEMORABILIA | HIGHLY ORIGINAL 1971 LAMBORGHINI MIURA P400 S LEADS EARLY COLLECTOR CAR HIGHLIGHTS | LI...

All-stock acquisition includes clinical-stage CD19/BCMA Dual-CAR T program Acquisition will expand existing advanced clinical-stage pipeline of amezalpat (PPAR ⍺ Antagonist, Phase 3-ready) and TPST-14...

SAN JOSE, Calif. , Nov. 17, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today ann...